{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Ainos, Inc."},"Symbol":{"label":"Symbol","value":"AIMD"},"Address":{"label":"Address","value":"8880 RIO SAN DIEGO DRIVE SUITE 800, SAN DIEGO, California, 92108, United States"},"Phone":{"label":"Phone","value":"+1 858 869-2986"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low dose oral form."},"CompanyUrl":{"label":"Company Url","value":"https://www.ainos.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Chun-Hsien Tsai","title":"Chairman, President &amp; Chief Executive Officer"},{"name":"Lawrence K. Lin","title":"Executive Vice President-Operations"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}